4//SEC Filing
Brennan Kevin M. 4
Accession 0001415889-23-012416
CIK 0001840233other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:35 PM ET
Size
5.5 KB
Accession
0001415889-23-012416
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Award
Stock Option (right to buy)
2023-08-16+25,000→ 25,000 totalExercise: $2.79Exp: 2033-08-15→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option award was granted on August 16, 2023 and shall vest with respect to 1/3 of the shares of common stock underlying the stock option on the first anniversary of the grant date and with respect to the remaining 2/3 of the shares of common stock underlying the stock option on the second anniversary of the grant date.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001971303
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 8:35 PM ET
- Size
- 5.5 KB